Coherus BioSciences Inc
NASDAQ:CHRS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Coherus BioSciences Inc
NASDAQ:CHRS
|
US |
|
Tsogo Sun Ltd
F:G5E
|
ZA |
|
R
|
Reliance Steel & Aluminum Co
SWB:RS6
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
Caseys General Stores Inc
NASDAQ:CASY
|
US |
|
D
|
Discover Financial Services
F:DC7
|
US |
|
T
|
Tuya Inc
F:785
|
CN |
|
G
|
Gatos Silver Inc
TSX:GATO
|
US |
|
Shinkin Central Bank
TSE:8421
|
JP |
|
Graco Inc
NYSE:GGG
|
US |
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
US |
|
T
|
Telefonaktiebolaget LM Ericsson
F:ERCG
|
SE |
|
BlackRock New York Municipal Income Trust
NYSE:BNY
|
US |
|
C
|
Chargeurs SA
F:GET
|
FR |
|
Kingfisher PLC
LSE:KGF
|
UK |
|
C
|
Chargeurs SA
SWB:GET
|
FR |
|
Caixabank SA
MAD:CABK
|
ES |
|
A
|
Aviakompaniya UTair PAO
MOEX:UTAR
|
RU |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
A
|
Avantor Inc
F:AVG
|
US |
|
Primo Brands Corp
F:V76
|
US |
|
Bidvest Group Ltd
F:NQL
|
ZA |
|
H
|
HB Fuller Co
F:HB1
|
US |
Bankruptcy Probability
Coherus BioSciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Coherus BioSciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Coherus BioSciences Inc
NASDAQ:CHRS
|
214.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
449.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
200.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Coherus BioSciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Coherus BioSciences Inc has total debt of 51.1m USD. This includes both short-term (0 USD) and long-term (51.1m USD) debt.
You can find a full breakdown on its Balance Sheet.
